|
|
Volumn 25, Issue 5, 1995, Pages 203-207
|
|
Intensive chemotherapy for anaplastic thyroid carcinoma: combination of cisplatin, doxorubicin, etoposide and peplomycin with granulocyte granulocyte colony-stimulating factor support. Chemotherapy Committee, The Japanese Society of Thyroid Surgery.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DOXORUBICIN;
ETOPOSIDE;
GRANULOCYTE COLONY STIMULATING FACTOR;
PEPLEOMYCIN;
AGED;
ARTICLE;
CARCINOMA;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
FEMALE;
HEMATOLOGIC DISEASE;
HUMAN;
MALE;
METASTASIS;
MIDDLE AGED;
MORTALITY;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
PILOT STUDY;
SQUAMOUS CELL CARCINOMA;
SURVIVAL RATE;
THYROID TUMOR;
THYROIDECTOMY;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
COMBINED MODALITY THERAPY;
DOXORUBICIN;
ETOPOSIDE;
FEMALE;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HEMATOLOGIC DISEASES;
HUMANS;
MALE;
MIDDLE AGED;
PEPLOMYCIN;
PILOT PROJECTS;
SURVIVAL RATE;
THYROID NEOPLASMS;
THYROIDECTOMY;
MLCS;
MLOWN;
|
|
EID: 0029391212
PISSN: 03682811
EISSN: None
Source Type: Journal
DOI: 10.1093/oxfordjournals.jjco.a039778 Document Type: Article |
|
Times cited : (28)
|
|
References (0)
|